20 hrs ago
Health Care Renewal
As the Door Turns - The Ongoing Interchange of Leaders Among Large...
The revolving door is the two-way conduit between leadership positions in government and industry that helps to enable health care, and maybe all of society, to be run by a group of insiders who can move easily between large or influential health care organizations and the government bodies that are supposed to regulate, oversee, and enforce laws ... (more)
The Indianapolis Star
Eli Lilly files patent suit to protect blood-thinner Effient
Eli Lilly and Co.' s corporate headquarters are shown at Delaware and McCarty streets in Indianapolis.
Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study
Correspondence: Dr PM Doraiswamy, Professor of Psychiatry, Duke University, Room 3550, Duke South Hospital, 1000 Trent Drive, Duke University Medical Center, Durham, 27710, NC,USAE-mail: email@example.com ; Dr MJ Pontecorvo, Avid Radiopharmaceuticals, 3711 Market Street, Philadelphia, PA, 19104, USA.
Facility Concerns Kill Lilly-Boehringer Diabetes Drug
Eli Lilly and Boehringer-Ingelheim said that the Food and Drug Administration didn't approve their diabetes treatment empagliflozin because of concerns about a facility where the drug will be made.
San Bernardino County Sun
Drug companies cutting back on marketing fees to doctors
The Eli Lilly and Co. corporate headquarters in Indianapolis. Eli Lilly & Co. is spending less on promotional speakers for its drugs now that Cymbalta and others have gone generic.
Stopping criminal access to APIs must not block generics, says expert
Criminal access to APIs must be cut off in a way that does not infringe generics companies' right to buy chemicals, a top US prosecutor told In-Pharmatechnologist.com.
Lilly diabetes drug meets late-stage goal
Eli Lilly and Co.' s experimental injectable diabetes treatment dulaglutide fared on par in a late-stage study with another drug that's already on the market.
Five Star Equities Issues New Research Reports on DVN, LLY, SIG and...
The stock traded between $63.31 and $65.64 on volume of 9.1 million shares traded.